Li T - Search Results

1

The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in China.

Ye J, Wang W, Xin L, Owen S, Xu L, Duan X, Cheng Y, Zhang H, Zhang S, Li T, Liu Y. Ye J, et al. Among authors: li t. Anticancer Res. 2017 Aug;37(8):4549-4556. doi: 10.21873/anticanres.11852. Anticancer Res. 2017. PMID: 28739751 Free article.

2

Clinicopathological classification and individualized treatment of breast cancer.

Hu H, Liu YH, Xu L, Zhao JX, Duan XN, Ye JM, Li T, Zhang H, Zhang S, Xiong Y. Hu H, et al. Among authors: li t. Chin Med J (Engl). 2013 Oct;126(20):3921-5. Chin Med J (Engl). 2013. PMID: 24157157

3

[Analysis of detecting value of ultrasound and the clinic-pathological features of axillary metastasis in breast cancer].

Xin L, Chen L, Zhang H, Liu Q, Xu L, Wang B, Li T, Duan X, Liu Y. Xin L, et al. Among authors: li t. Zhonghua Wai Ke Za Zhi. 2014 Dec;52(12):924-8. Zhonghua Wai Ke Za Zhi. 2014. PMID: 25622584 Chinese.

4

Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy.

Liu S, Duan X, Xu L, Xin L, Cheng Y, Liu Q, Ye J, Zhang S, Zhang H, Zhu S, Li T, Liu Y. Liu S, et al. Among authors: li t. Breast Cancer Res Treat. 2015 Nov;154(2):239-49. doi: 10.1007/s10549-015-3617-7. Epub 2015 Oct 26. Breast Cancer Res Treat. 2015. PMID: 26498019

5

[Neoadjuvant treatment in human epidermal growth factor receptor 2-positive breast cancer].

Liu Y, Liu S, Zhang H, Xu L, Li T, Duan X. Liu Y, et al. Among authors: li t. Zhonghua Wai Ke Za Zhi. 2015 Dec 1;53(12):901-4. Zhonghua Wai Ke Za Zhi. 2015. PMID: 26850663 Chinese.

6

[Analysis on clinical and pathological characteristics of 66 patients with stage IV breast cancer].

Gao G, Zhang H, Zhang S, Liu Q, Xu L, Ye J, Duan X, Li T, Liu Y. Gao G, et al. Among authors: li t. Zhonghua Wai Ke Za Zhi. 2015 Dec 1;53(12):935-40. Zhonghua Wai Ke Za Zhi. 2015. PMID: 26850666 Chinese.

7

[Predictive factors of pathological complete response in primary human epidermal growth factor receptor 2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy].

Liu S, Xu L, Zhang H, Zhang S, Li T, Duan X, Liu Y. Liu S, et al. Among authors: li t. Zhonghua Wai Ke Za Zhi. 2016 Feb 1;54(2):94-8. doi: 10.3760/cma.j.issn.0529-5815.2016.02.004. Zhonghua Wai Ke Za Zhi. 2016. PMID: 26876074 Chinese.

8

A retrospective prognostic evaluation analysis using the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system for luminal A breast cancer.

Ye J, Wang W, Xu L, Duan X, Cheng Y, Xin L, Zhang H, Zhang S, Li T, Liu Y. Ye J, et al. Among authors: li t. Chin J Cancer Res. 2017 Aug;29(4):351-360. doi: 10.21147/j.issn.1000-9604.2017.04.08. Chin J Cancer Res. 2017. PMID: 28947867 Free PMC article.

9

Clinicopathologic analysis of 722 breast cancer patients who met the inclusion criteria of the TAILORx trial.

Xiang HY, Liu YH, Zhang H, Zhang S, Xin L, Xu L, Ye JM, Li T, Duan XN, Liu Q. Xiang HY, et al. Among authors: li t. Chin Med J (Engl). 2019 Dec 20;132(24):2914-2919. doi: 10.1097/CM9.0000000000000548. Chin Med J (Engl). 2019. PMID: 31809316 Free PMC article.

10

Retrospective analysis of sentinel lymph node biopsy using methylene blue dye for early breast cancer.

Yang S, Xiang HY, Xin L, Zhang H, Zhang S, Cheng YJ, Liu Q, Xu L, Li T, Duan XN, Ye JM, Liu YH. Yang S, et al. Among authors: li t. Chin Med J (Engl). 2021 Jan 11;134(3):318-325. doi: 10.1097/CM9.0000000000001359. Chin Med J (Engl). 2021. PMID: 33522727 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,089 results

Search Page

Filters